How to Choose Between Wegovy or Mounjaro Online
Wegovy or Mounjaro: Understanding Your Online Prescription Options
When seeking an online prescription for weight management, understanding the fundamental differences between Wegovy or Mounjaro helps inform your decision. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist that works on two hormone pathways simultaneously. Both are prescription-only medicines requiring clinical assessment by licensed UK prescribers. EverydayMeds provides access to both treatments through our comprehensive online consultation process, ensuring you receive the most appropriate medication for your individual circumstances.
The online prescription process removes traditional barriers whilst maintaining clinical safety standards. Our GPhC-registered pharmacy (#9012878) ensures every consultation meets MHRA requirements for remote prescribing. Licensed prescribers evaluate your medical history, current medications, BMI, and weight-related health conditions to determine whether Wegovy or Mounjaro aligns with your treatment goals. This thorough assessment typically takes 3 minutes to complete online, with prescriber review conducted within 3 working days for standard service or 24 hours for express processing.
Wegovy or Mounjaro Pricing: Transparent Online Prescription Costs
Understanding the cost structure for Wegovy or Mounjaro online prescriptions helps you plan your weight management investment effectively. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (weeks 1-4), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. New customers can apply code FIRST40 at checkout, whilst returning customers use DOSE25 to access these prices. Our bundle options include the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, providing three months of step-up dosing in one convenient order.
Mounjaro follows a different pricing structure, though both treatments are available through the same streamlined online prescription process. The consultation fee covers prescriber assessment, clinical review, and prescription generation for either medication. Payment is processed securely at checkout, with next-day cold-chain delivery ensuring your medication arrives in optimal condition. Both Wegovy and Mounjaro require the same level of clinical oversight, making the prescription process identical regardless of which treatment your prescriber recommends.
Clinical Evidence: Wegovy or Mounjaro Research Foundations
Clinical trials demonstrate the effectiveness of both Wegovy and Mounjaro when used alongside reduced-calorie diet and increased physical activity. In the STEP 1 trial, participants taking Wegovy achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme encompassed multiple studies, including STEP 2 showing clinically studied weight loss in patients with type 2 diabetes, and STEP 5 demonstrating 15.2% sustained weight loss at 2 years.
Mounjaro's clinical evidence comes from the SURMOUNT trial programme, though direct comparison between trials isn't appropriate due to different study designs and participant populations. Both medications have received MHRA approval for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities. Your prescriber will discuss relevant clinical evidence during your online consultation to help determine whether Wegovy or Mounjaro best suits your medical profile and treatment objectives.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally produced in your intestines after eating. This mechanism promotes feelings of fullness and satiety, potentially reducing appetite and food cravings through direct action on brain appetite centres. The medication slows gastric emptying, meaning food remains in your stomach longer, contributing to sustained feelings of fullness after smaller meals. Administered once weekly via FlexTouch pen injection, Wegovy provides consistent hormone activity throughout the week. Clinical studies suggest this mechanism may help patients consume fewer calories naturally, supporting weight management goals when combined with lifestyle modifications.
Online Prescription Process: From Assessment to Delivery
Obtaining your Wegovy or Mounjaro prescription online begins with our comprehensive 3-minute clinical assessment covering medical history, current medications, BMI calculation, and weight-related health conditions. The assessment includes specific questions about contraindications, previous weight loss attempts, and treatment expectations to ensure appropriate prescribing. Licensed UK prescribers review each submission individually, conducting thorough medical evaluations before approving prescriptions. Standard review takes 3 working days, though express 24-hour processing is available for urgent requirements. Once approved, medications are dispatched via next-day delivery using temperature-controlled packaging to maintain cold-chain integrity throughout transit.
Storage and Practical Considerations for Wegovy or Mounjaro
Both Wegovy and Mounjaro require refrigerated storage at 2-8°C before first use, though Wegovy offers a storage advantage with 6 weeks room temperature tolerance compared to Mounjaro's 21 days. This difference can be significant for travel or lifestyle flexibility. Wegovy uses the FlexTouch pen system, providing precise dose delivery with clear visual confirmation of injection completion. Dose escalation follows a mandatory schedule: 0.25mg for weeks 1-4, 0.5mg for weeks 5-8, 1mg for weeks 9-12, 1.7mg for weeks 13-16, and 2.4mg for maintenance from week 17 onwards. Both medications require injection once weekly, typically on the same day each week for consistency.
Wegovy or Mounjaro: Personalised Prescription Matching
The decision between Wegovy or Mounjaro depends on individual medical factors that our prescribers evaluate during online consultation. Patients with certain medical histories may be more suitable for one treatment over the other, whilst medication interactions or contraindications can influence prescriber recommendations. Some patients respond differently to GLP-1 monotherapy versus dual GIP/GLP-1 agonism, though individual response cannot be predicted without trial.
Our prescribers consider your complete medical profile, treatment preferences, lifestyle factors, and cost considerations when recommending Wegovy or Mounjaro. Both treatments require commitment to dietary changes and increased physical activity for optimal effectiveness. The online prescription process allows detailed discussion of expectations, potential side effects, and monitoring requirements before treatment commencement.
Start Your Wegovy or Mounjaro Journey Today
Ready to begin your weight management journey with professional medical support? Complete our 3-minute online assessment to discover whether Wegovy or Mounjaro suits your needs best. New customers can use code FIRST40 at checkout, whilst returning customers apply DOSE25 for optimised pricing. Visit https://everydaymeds.co.uk/collections/wegovy to begin your consultation with our licensed prescribers. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance whilst providing convenient access to these life-changing prescription-only medicines. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which is right for you.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
